EP 1846105 A2 20071024 - USE OF ADRENERGIC ALPHA2B ANTAGONISTS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS
Title (en)
USE OF ADRENERGIC ALPHA2B ANTAGONISTS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS
Title (de)
VERWENDUNG VON ADRENERGEN ALPHA-2B-ANTAGONISTEN ZUR BEHANDLUNG VON VASOMOTORISCHEN SYMPTOMEN
Title (fr)
UTILISATION D'ANTAGONISTES ALPHA-2B POUR LE TRAITEMENT DE SYMPTOMES VASOMOTEURS
Publication
Application
Priority
- US 2004033754 W 20041013
- US 51089703 P 20031014
- US 68581203 A 20031014
- US 0332759 W 20031015
- US 96289704 A 20041012
Abstract (en)
[origin: WO2005037260A2] The present invention relates to selective adrenergica2B antagonists alone, selective adrenergicalpha2B antagonists in combination with norepinephrine reuptake inhibitors (NRI) (as a single compound or as a combination of two or more compounds), or selective adrenergicalpha2B antagonists in combination with dual norepinephrine reuptake inhibitors/serotonin reuptake inhibitors (NRI/SRI) (as a single compound or as a combination of two or more compounds) and methods of their use in the treatment of vasomotor symptoms.
IPC 8 full level
A61P 5/00 (2006.01); A61K 31/00 (2006.01); A61K 31/13 (2006.01); A61K 31/137 (2006.01); A61K 31/138 (2006.01); A61K 31/155 (2006.01); A61K 31/167 (2006.01); A61K 31/381 (2006.01); A61K 31/4174 (2006.01); A61K 31/4178 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/5377 (2006.01); A61K 31/55 (2006.01); A61K 45/06 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); A61K 31/13 (2013.01); A61K 31/137 (2013.01); A61K 31/138 (2013.01); A61K 31/155 (2013.01); A61K 31/167 (2013.01); A61K 31/381 (2013.01); A61K 31/4174 (2013.01); A61K 31/4178 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/5377 (2013.01); A61K 31/55 (2013.01); A61K 45/06 (2013.01); A61P 5/00 (2017.12); A61P 9/00 (2017.12)
Citation (search report)
See references of WO 2005037260A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL HR LT LV MK
DOCDB simple family (publication)
WO 2005037260 A2 20050428; WO 2005037260 A3 20070816; AU 2004281750 A1 20050428; EP 1846105 A2 20071024; MX PA06003866 A 20060703
DOCDB simple family (application)
US 2004033754 W 20041013; AU 2004281750 A 20041013; EP 04794977 A 20041013; MX PA06003866 A 20041013